275 filings
Page 8 of 14
8-K
e76u4n70ejh5 9am
19 Nov 20
Moleculin Announces New Data Demonstrating
4:00pm
8-K
m3kz5yqbw10ka3
13 Nov 20
Moleculin Biotech, Inc. Reports Financial Results
7:29am
8-K
ynoja85i
29 Oct 20
Moleculin Announces Additional Collaboration on Drug Candidate Targeting COVID-19
7:29am
8-K
i9s5ol66
21 Oct 20
Moleculin Announces Independent Study Validates Annamycin’s Ability to Target Lung Localized Tumors, Further Supporting IND
7:29am
8-K
rdi yuhvnyp9
13 Oct 20
Moleculin Announces Additional Positive Interim Results in Adult Glioblastoma Clinical Trial
7:29am
8-K
4ib2wx kkg9bvyw
7 Oct 20
Departure of Directors or Certain Officers
4:35pm
8-K
molilf
6 Oct 20
Moleculin Announces New Antiviral Drug
7:29am
8-K
kstzm 0h3hm4pk7
2 Oct 20
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
w69ii51m
1 Oct 20
Moleculin Announces Positive Interim Results in Pediatric Brain Tumor Phase 1 Clinical Trial at WP1066 demonstrates activity in DIPG, rare form of pediatric brain tumor
7:30am
8-K
47sd64u
29 Sep 20
Moleculin Announces Discovery of Significant In Vitro Activity Against COVID-19 Virus for New
7:30am
8-K
i6ewlqt2eybvywii
14 Sep 20
Moleculin Announces COVID-19 In Vivo Testing Contracted for WP1122
4:30pm
8-K
x7qg8f5o 3ud
14 Sep 20
Regulation FD Disclosure
4:04pm
8-K
0tiu6st2ddg4fuanaf9f
9 Sep 20
Moleculin Announces Successful Completion of Pre-IND Meeting with the FDA
7:30am
8-K
67q8o7iji7em
1 Sep 20
Regulation FD Disclosure
4:18pm
8-K
rsofccfl
26 Aug 20
Departure of Directors or Certain Officers
4:12pm
8-K
8a5ig09iqj
12 Aug 20
Results of Operations and Financial Condition
7:32am
8-K/A
z1059z2meqdseq
4 Aug 20
Submission of Matters to a Vote of Security Holders
12:00am
8-K
qw0nh5f89bi
21 Jul 20
Moleculin Announces New Independent In Vitro Testing Confirms Antiviral Activity of WP1122 in Coronavirus
8:41am
8-K
00grtk87g usgsf1g6
17 Jul 20
Entry into a Material Definitive Agreement
5:19pm
8-K
hgrjzzy 2knbe
15 Jul 20
Moleculin Announces Agreement to Produce WP1122 for Expanded Development of Potential COVID-19 and Oncology Drug Candidate
7:30am